What is Retatrutide?

Is Retatrutide (Triple Incretin Agonist) the Next-Gen Research Compound? Retatrutide is a synthetic investigational peptide developed as a triple agonist of the GIP, GLP-1, and glucagon receptors. By activating all three incretin pathways simultaneously, it represents the next generation of…